HPS Pharmacies wish to advise that Sanofi-Aventis Australia has given notice of the discontinuation of:
Rythmodan 150mg Capsules
Rythmodan 150mg capsules will be discontinued on 1st September 2016. However, Rythmodan 100mg capsules will continue to be available. Rythmodan contains disopyramide; a class 1a antiarrhythmic which is indicated for the management of ventricular arrhythmias.
Please retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Sanofi-Aventis Australia on 1800 818 806.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.